By /

Industry Growth Program (IGP) Grant Support

Up to $5M in matched funding for Australian SMEs ready to commercialise and scale new technology – if you fit an NRF priority area.

Check if you’re competitive for IGP

15-minute check. We’ll tell you if it’s worth applying, and what to fix if it isn’t.

Google logo ★★★★★ 4.8 from 250+ reviews

Building genuinely new tech? The Industry Growth Program (IGP) can help you turn it into something that sells. It starts with the IGP Advisory Service (think of it as the gate). If you’re a strong fit, you can then go for matched funding through Early-Stage Commercialisation or Commercialisation & Growth. Most teams get screened out on the basics, so it helps to be clear early: you need to be an Australian SME and your project should sit in an NRF priority area.

At a glance

  • Grant amount – $50k–$250k (Early-Stage Commercialisation) or $100k–$5m (Commercialisation & Growth)
  • Funding style – matched funding (you contribute too)
  • Eligibility snapshot – Australian SME, aligned to an NRF priority area, with a real commercial plan
  • Pathway – IGP Advisory Service first, then (if you’re invited) the grant application
  • Best use cases – prototype to pilot, validation, market entry, scaling
  • Common mistake – spending early before the agreement is signed (it can kill eligibility)

What is the Industry Growth Program (IGP)?

The Industry Growth Program (IGP) is built around a simple idea:

prove the commercial case first, then fund the best projects.

You start with the IGP Advisory Service, where an adviser tests your business model, IP, go-to-market plan, and the risks that could derail delivery. If your project is assessed as competitive, you can then apply for matched funding under Early-Stage Commercialisation or Commercialisation & Growth.

Who is the Industry Growth Program (IGP) for?

The Industry Growth Program (IGP) suits Australian SMEs developing something that lifts national capability in a National Reconstruction Fund (NRF) priority area. The priority areas are

  • resources value-add
  • agriculture, forestry and fisheries value-add
  • transport
  • medical science
  • renewables and low emissions
  • defence capability
  • enabling capabilities

To be eligible, you’ll usually need to be Australian-incorporated, GST-registered, and under $20m turnover in each of the last three years. It’s generally not for individuals, or projects that are mainly “business-as-usual” upgrades.

What’s eligible under the Industry Growth Program (IGP)?

Projects that move you along the commercialisation curve, such as

  • Early-Stage Commercialisation – feasibility, proof of concept, early prototypes, and small-scale testing (including simulated environments)
  • Commercialisation & Growth – prototyping to market readiness, pilots or low-rate production, regulatory or quality systems, first customers, and scaling plans

Projects that are mainly “business-as-usual”, minor iterations, internal-only upgrades, or pure sales and marketing spend once you’ve already proven meaningful sales.

Quick examples of what tends to win

  • Medtech (TRL 5–7) – clinical-grade prototype validation, pilot with a hospital partner, TGA pathway planning, quality system setup
  • Advanced manufacturing (TRL 6–8) – low-rate production line, QA systems, supplier qualification, export-readiness testing
  • Clean energy (TRL 6–9) – field pilots with an industry partner, certification, performance data to prove cost-down at scale

How much funding can you get under the Industry Growth Program (IGP)?

The IGP offers matched funding across two streams, and the amount you can access depends on where you are on the commercialisation path.

  • Early-Stage Commercialisation – $50k to $250k, usually 50% matched, minimum eligible spend of $100k, up to 10% in-kind may be accepted, typically 6 to 24 months.
  • Commercialisation & Growth – $100k to $5m, usually 50% matched, minimum eligible spend of $200k, cash co-contribution only, typically 12 to 24 months.

A simple way to think about co-funding is that an $800k project often looks like $400k grant plus $400k cash from you. In many cases, other government funding can’t be counted as your cash match.

For the latest rules, point people to the Industry Growth Program guidance on business.gov.au.

How to apply for the Industry Growth Program (IGP)

Applying for the IGP is usually a two-step pathway. You start with the Advisory Service, then (if you’re invited) you apply for matched funding.

  1. IGP Advisory Service (open anytime) – Apply online. If you’re eligible, you’ll be assigned an adviser and you’ll receive a Commercialisation & Growth report.
  2. Grant application (invite only) – Use your report to choose Early-Stage Commercialisation or Commercialisation & Growth, then submit. Assessment is rolling and merit-based.

Pro tip
Have a short “runway plan” ready – cash position, milestones, key risks, and any partners or customers you can name. It makes the advisory step much faster.

If you want a straight view on competitiveness before you invest time,  book a quick strategy call.

Mistakes to Avoid

Before you sink hours into an application, here are the ten traps we see most often — and how to sidestep them.

  1. Business-as-usual dressed as innovation — If it’s an efficiency tidy-up, it won’t score. Show a step-change and tie it clearly to an NRF priority. Spell out the capability you’re adding to Australian industry.
  2. Wrong stream / TRL mismatch — Early-Stage = proof and early prototypes. Commercialisation & Growth = pilots, first customers, scaling. State your current TRL and target TRL so assessors don’t have to guess.
  3.  Starting work too early — Signing a contract or kicking off before the funding agreement makes those costs ineligible. Line up the work; don’t start it.
  4. Shaky co-funding — It’s 50/50 cash. Show banked funds or a facility and include the accountant letter. Don’t plan to use other government grants for your share.
  5. Hand-wavy market path — TAM slides don’t convert. Name channels, pilots, and actual customers with timelines. Show how leads become revenue.
  6. Weak additionality — Explain the “with vs without” case. What gets brought forward, de-risked or scaled because of IGP? Be explicit.
  7. Unclear IP and control — If uni IP, licences or background IP are involved, show who owns what, who can commercialise, and any freedom-to-operate work done.
  8. Partner proof missing — Verbal support doesn’t count. Get signed letters that state roles, resources and dates. Put partners into your milestones.
  9. Budget that doesn’t track to milestones — Every dollar should land on a milestone with an owner and date. Keep overseas spend to what’s unavoidable and justify it. Avoid “full plant” capex at this stage; focus on pilot/low-rate production.
  10. Risk, regs and polish — Call out technical, market, supply, regulatory and cyber/security risks with concrete mitigations. Then submit clean: plain language, no orphan acronyms, word limits observed, each criterion answered directly.

If you want a blunt pre-flight check, we can run your project against this list and tell you where you’ll score — and where you won’t.

How to Nail the Advisory Service (Stage 1)

  1. Problem — one line that names who hurts, how much, and why it matters.
    e.g., “Food processors lose ~8% yield to downtime; our control system cuts it ~30%.”
  2. Proof so far — 3–4 sentences on what exists, where it ran, and the result (with a metric).
    “Prototype ran 200 hours in a live plant; OEE improved 7.4%.”
  3. TRL now → target — say today’s TRL and what the next pilot gets you to, with timing.
    “Currently TRL 5; a 6-month pilot gets us to TRL 7.”
  4. NRF fit — name the exact NRF priority and the Australian capability you lift (sovereign supply, skills, local content).
    “Renewables & low emissions — we localise grid-edge optimisation and reduce import reliance.”
  5. Customers & path — name segments, a couple of real logos/letters, and your channel strategy.
    “Two LOIs (Company A, B). Direct for first 10 sites, then distributor/OEM.”
  6. Team & gaps — who runs delivery, what you’ll add, when you’ll add it (name people, not just roles).
    “Delivery lead: Sarah (Ops). Contract QA specialist in Q2.”
  7. Risks & mitigations — one-liners with an owner and the fix.
    “Supply risk — dual-source by Month 4 (Owner: Ops). Certification risk — pre-assessment booked (Owner: QA).”
  8. What you want from the Adviser — the specific help that unblocks you (pilot design, QA/regs, pricing, scale-up).
    “We want help to design the 6-site pilot, lock the pricing model, and map ISO 13485.”
  9. Co-funding reality — confirm you can match later (cash/facility); keep it to one sentence.
    “50/50 cash match covered via facility X and retained earnings.”
  10. Attachments that matter — one-page snapshot, short CVs, LOIs/MOUs, tiny risk register, and a budget↔milestone map.
    Keep it light; they’re scanning for readiness, not a thesis.

How to Answer the Merit Criteria (Grant Stage)

  1. Alignment with IGP & NRF — name the NRF area, the capability uplift here in Australia, and why now/why you.
    “Medical science: localise sterile device assembly (ISO 13485). +12 FTEs, 70% local content, import lead times 18→3 weeks.”
  2. Capability & delivery — show you can execute with a milestones mini-table (date, owner, output, success metric) and name facilities/partners you control.
    “Milestone 2 (Owner: Ops): low-rate production 1,000 units/month by Month 8; evidence = batch records, QA ≥98%.”
  3. Market opportunity & pathway — skip TAM; talk named demand, pipeline by stage, channel plan and unit economics.
    “Ten-site pipeline (3 LOIs, 2 pilots booked). Price $4,900; COGS $2,350; GM 52% at scale.”
  4. Benefits of the grant (additionality) — write the with-vs-without story; quantify time brought forward, scale unlocked, and jobs/capital/exports.
    “Without IGP, TRL 7 slips 12 months. With IGP, pilot line live in 6 months; +14 FTEs; $6.4m order book unlocked.”
  5. Budget ↔ milestones — map every dollar to a milestone, owner and evidence. Justify any overseas spend; avoid “full plant” capex — focus on pilot/low-rate capability.
    If we can’t trace a line item to a milestone, it won’t score well.
  6. IP & freedom to operate — who owns background vs project IP, licence terms, FTO search/opinion; if uni IP, summarise the deed/option and commercial rights.
    Clarity here de-risks the whole application.
  7. Risk & regulatory — call out technical, market, supply, regulatory and cyber/security risks with named owners and mitigations; outline TGA/CE, grid/safety or export controls with timing where relevant.
    Don’t bury it — this is where mature projects stand out.
  8. Partners that count — letters should state role, resources, dates, why you, and post-pilot intent; then tie those commitments into your milestones (not just the appendix).
    Verbal support doesn’t score.
  9. Benefits & metrics — the numbers a panel actually wants: FTEs by year, skills uplift, private capital leveraged, export share, unit economics at scale, local content, emissions where relevant.
    Make them measurable and time-bound.
  10. Tone & format — lead each answer with a result sentence, then 2–3 short lines; use bold micro-headings (e.g., Problem, Evidence, Milestone, Owner); name people; cut adjectives, keep numbers.
    Readable beats clever — every time.

Who’s Bulletpoint (and why we’re fussy)

Thanks for sticking with me to the end. We do two things, really well: grants and the R&D Tax Incentive. And we’re upfront about fit. We pre-score every project and only take on work we rate at 80%+ chance of success. If we don’t choose to work with you, it’s not a judgment on the idea — it’s us protecting your time (and ours). You get a clear read, not a drawn-out maybe.

What that means for you:

  • Straight call, early — if it’s not competitive, we’ll say so and why.
  • Focus where it counts — keep growing, raising finance, or use us to maximise your R&D Tax Incentive while the grant matures.
  • Proven process — $100M+ in grants secured, 4.8★ from 250+ reviews, audit-safe docs, fixed fees, no fluff.

Want an honest, 15-minute read on competitiveness? Book below. If it’s an R&D Tax question, use the R&D link — we’ll give you a yes/no/what’s missing and a quick audit sense-check.

Ready to Shape a Winning Application?

We don’t just check eligibility — we help you build a submission that hits the mark.

IGP eligibility or competitiveness? Get a straight answer. Book a Free Strategy Call

Grant Recipients (Early‑Stage Commercialisation Grants)

Advance Green Embedded Lending for Home Energy Upgrades

28Watt is developing a digital service to enable green financing for home energy upgrades, with the funding supporting product development, market validation, and scalable deployment.

Commercialise Sleep‑Wearable Device
Affectable is refining its “Affectable Sleep” wearable through user trials and early manufacturing, supported by funding for design, IP and market readiness.

Deploy Herbicide‑Free Weed Control Technology
Azaneo is building a beta unit of its pulsed electric field weeding system, enabling growers to adopt sustainable, herbicide‑free weed control.

Scale Green Methanol Production from Biogas
Birra Technologies is advancing a bench‑scale prototype that converts carbon‑neutral biogas into marine‑grade green methanol fuel, supported by this funding.

Commercialise Biological Neuro‑computing Platform
Cortical Labs is scaling its CL1 cloud‑accessible biological computing prototype, enabling research entities to access synthetic biological intelligence hardware and software.

Validate Coiled‑Tubing Geothermal Drilling System
CoilRig is finalising performance testing of its coiled‑tubing geothermal rig for U.S. deployment, with funding supporting lab and simulated field validation.

Pilot On‑Farm Solar & Hydrogen Production Plant
Farm Harvest Direct is building and validating a 50 kW pilot solar power plant as a stepping stone to a 3 MW facility and hydrogen fuel production on‑farm.

Scale Black Soldier Fly Breeding Technologies
Flyfarm Queensland is testing its patented insect breeding and hatchery systems with micro‑climate control to enable future full‑scale operations.

Develop Autonomous Blueberry Harvester
Forager Automation is creating a robotic harvester for small fruits to reduce labour costs and boost yield efficiency for growers.

Manufacture Prescription Screen Protectors Without Glasses
Forgetspecs.com is producing prototypes of its ‘Golden Sample’ screen protector to enable device use without glasses, supported by advanced manufacturing techniques.

Deploy Remote Monitoring Camera for Agriculture
Innovation Industries is developing a low‑signal remote monitoring camera for livestock and agriculture infrastructure, enhancing rural visibility and security.

Scale Cultivated Meat Production from iPSC Lines
Magic Valley is scaling production of cultivated meat using sheep and pig iPSC lines, moving from research into commercial production.

Accelerate Modular Neurotech Prototyping Platform
Neo‑Bionica is reducing prototyping time for neuro‑technology from years to months, supported by manufacturing and commercialisation activities.

Commercialise Proprietary Braking System for E‑Mobility
One Brake is developing a braking system for e‑bikes, bicycles and motorcycles that reduces stopping distances and improves rider safety.

Launch Reusable Space‑Debris Capture Technology
Paladin Space is commercialising Triton, a reusable robotic system for space‑debris removal, with lab demonstrations and zero‑gravity flight testing enabled by the funding.

Scale Banana‑Fibre Packaging Technology
Papyrus Australia is building a small‑scale prototype plant converting banana plantation waste into 100% biodegradable packaging.

Commercialise MS Diagnostic & Prognostic Blood Tests
Proheme Diagnostics is advancing two innovative blood tests for MS toward global markets.

Scale Seed‑Treatment “Lightning as a Service” Platform
Rainstick is advancing its high‑voltage seed‑treatment solution to process 1kg of seeds daily as a key commercial entry step.

Feasibility Study for Seaweed Biomass Growth Facility
SeaStock is conducting a feasibility study for a prototype asparagopsis growth facility to support sustainable supply chains.

Prototype Elevated Vertipad for Urban Air Mobility
Skyportz is developing a vertipad design and prototype to support safe high‑density air taxi operations.

Commercialise Auditory Training Tool for Children
Sound Scouts HQ is advancing a tool to improve children’s listening ability in noisy environments.

Commercialise Supercritical‑Water Soil Amendment Process
Stoney Pinch Sands is scaling its chemical‑free method to address silica deficiency in soils.

Develop Lightweight Hydrogen Fuel Cell for Aircraft
Stralis Aircraft is advancing its lightweight fuel‑cell propulsion technology to reduce aircraft operating costs.

Commercialise Novel Isotope‑Separation Technology
Ubaryon is scaling a new isotope‑separation process that supports uranium enrichment capabilities.

Develop Digital Twin of the Global Food System
Uncharted Waters is progressing its digital twin tool for agri‑food sector risk and opportunity analysis.

Pilot Critical‑Minerals Processing Plant
Watts & Fisher is advancing pilot‑scale processing for dissolving and purifying valuable metals more efficiently.

Grants Recipients (Commercialisation & Growth Grants)

Battery Powered Transport Trailer (EdgeVolt L, XL)
3ME Technology will commercialise four battery-powered transport trailers for industrial applications including mining, defence, construction and ports, enabling remote control and autonomous operation for reduced emissions and operating costs.

Persistent Undersea Surveillance for Australia and our Allies
Acacia Systems is commercialising technology for naval uncrewed surface vehicles that enables persistent underwater surveillance, helping to protect Australia’s maritime approaches from sub-surface threats.

Robotic Micro Precision Dosing for Multi-characteristic Powders
Accurate Dosing Systems has developed an automated robotic dosing system that accurately handles diverse powdered ingredients under varying climatic conditions, supporting improved manufacturing in food, fragrance and pharmaceutical sectors.

Grow Global Sales by Leveraging Production Capability to Increase Exports
ActionLaser will commercialise its laser-drilled filtration screens, enabling manufacturing scale-up and targeting new export markets including sugar beet processing, dairy automation, plastics recycling and mineral processing.

Rapid Growth: from Commercial Pilot to Mass Manufacturing
Allegro Energy is scaling manufacturing of its new battery electrolyte for long-duration redox flow energy storage, reducing cost and improving sustainability through safer, high-performance materials.

Shared Solar Innovation – Technology Roadmap Development and Commercialisation
Allume Energy will advance commercial deployment of its SolShare technology, which enables residents in multi-unit buildings to share onsite solar power, reducing energy bills and improving access to renewable energy.

Commercialising Alt. Leather from Lab-scale to Pilot-scale Production
Alt Materials is moving its 100% bio-based leather alternative into pilot-scale manufacturing and preparing for market entry through partnerships with sustainable materials and consumer goods manufacturers.

Lightway Sentry: Optical Power for Unlimited Drone Flight
Aquila Space Technologies will commercialise a wireless energy system capable of powering drones during flight, enabling unlimited airtime and positioning the business as a leader in wireless power transfer.

Growth and Commercialisation of Autonomous Optical Solutions
Arkeus will scale manufacturing of autonomous optical search and surveillance systems for defence and civil applications, taking proven prototypes into commercial production environments.

Athena Helios: Trusted and Assured AI for Global Military Applications
Athena Artificial Intelligence will commercialise its AI-driven decision-support platform for defence, building sovereign capability in advanced military technologies and supporting international market expansion.

Decarbonising Global Aquaculture Using Wave Powered Technology
Blue Carbon is deploying its oPod prototype into commercial salmon farming operations to improve water circulation and oxygenation using renewable wave energy, supporting healthier and more sustainable aquaculture.

Unphish: Addressing Omni-channel Threats via Unified & Automated Reporting
Brandsec is commercialising Unphish, a cybersecurity enforcement platform that automates identification and removal of malicious online content including phishing domains, compromised sites and fake social media accounts.

Cauldron Precision Fermentation 10kL Facility: Unlocking Industry TRL4-8
Cauldron Molecules is building a fully automated precision fermentation facility to reduce biomanufacturing costs and unlock commercial-scale production opportunities for emerging advanced manufacturing markets.

World-first Commercially-operating Foiling Pilot Boat
Caulmar, trading as Hart Marine, is developing a low-emission foiling pilot boat that reduces drag and fuel use while improving speed and safety, with Australian manufacturing and global sales expansion planned.

Commercialisation of Tactile Sensor-enabled Smart Gripper
Contactile is commercialising a robotic gripper with a human-like sense of touch that measures force, torque, vibration and slip, enabling dexterous automation within industrial environments.

CiTech Nexus 16 Commercialisation
Critical Infrastructure Technologies will scale manufacturing of a rapidly deployable radio communications tower that combines power, communications and equipment housing inside a standard shipping container footprint.

Autonomy Stack Commercialisation for Priority Robotics Applications
Cyborg Dynamics Engineering is advancing autonomous robotics technologies for defence, resources and environmental applications by developing key functionality required for commercial deployment.

Commercialisation of Hybrid Dairy-plant Products for Growth and Export
DFDU is investing in new equipment to scale production of hybrid dairy-plant cheeses and creams that deliver strong taste performance while expanding export opportunities.

Disruptive User Testing: Prioritising Overlooked Edge Cases for Equity
Digital Discovery is scaling its See Me Please accessibility platform, enhancing machine learning redaction and multimodal AI capabilities to improve inclusion in digital user experience testing.

Electrogenics MOSkin – Innovative Patient Radiation Dosimeter
Electrogenics Laboratories is commercialising an in-vivo radiation dosimetry system that enables more accurate measurement during radiotherapy and reduces risks of patient under- or over-exposure.

First Responder Brain Scanner to Reduce Burden of Stroke and Brain Injury
EMVision is accelerating commercial deployment of a portable brain scanner that provides rapid neurodiagnostics in ambulances, supporting earlier treatment for stroke and traumatic brain injury and establishing sovereign manufacturing capability.

Endua AHEAD – Advanced Hydrogen Electrolyser for Australian Decarbonisation
Endua will scale development of its proton exchange membrane electrolyser technology to reduce the cost of hydrogen production and strengthen domestic capability in clean energy manufacturing.

Commercialisation of a Mill Liner Bolted Joint Life Management System
Engentus is commercialising its JEMTEC technology to improve the reliability of bolted joints in mining equipment, enabling operational efficiency gains and partnerships with global industry suppliers.

Commercialising Innovative Next-generation Graphene Ultracapacitors
EnyGy will validate and scale graphene-based ultracapacitors that deliver improved energy density, efficiency and reliability for transport, renewable energy and industrial applications.

Development of an Innovative Asset Integrity Product Platform
Evosonic is commercialising AI-powered non-destructive testing equipment to improve asset reliability in defence, mining, space, and energy sectors, reducing reliance on specialist skills.

Commercialising the GreaseBoss Heavy Mobile Equipment Solution
GB Operations is scaling deployment of its grease management technology for heavy industrial machinery, reducing manual error and improving equipment maintenance across mining, agriculture and civil sectors.

LunaX 3D Tissue Culture – AI-powered Non-animal Models for Drug Development
Gelomics is commercialising its LunaX 3D tissue culture system to accelerate drug discovery and scale intelligent photocuring hardware, while protecting IP and expanding market access.

Australian Liquid Rocket Engines for Larger Commercial Launch Vehicles
Gilmour Space Technologies is advancing development of its sovereign liquid rocket engines to power more capable rockets carrying commercial and defence payloads into orbit.

Advanced Materials Vulloy Production Line Processing Capability
Gravitas Technologies will build a commercial-scale facility for Vulloy, an advanced alloy engineered for high-temperature environments, improving supply chain resilience and export potential.

Improving Sustainability and Nutrition in Meats Using Australian Crops
Harvest B is commercialising blended plant-animal protein products that enhance nutrition and eliminate gluten by adopting Australian faba bean-based formulations to support scaling and consumer adoption.

Development of a Mobile Rapidly Deployable Large Format 3D Printing System
Hyperion Systems will scale its mobile robotic 3D printing system, housed within a shipping container, enabling onsite fabrication of large components within days to improve productivity and reduce logistics costs.

BlueCheck Manufacturing Scale-up and Market Growth
Incisive Technologies is commercialising BlueCheck, a dental paint that enables early detection of tooth decay, aiming to scale production and expand adoption across domestic and global dental markets.

Hyperion: Space Situational Awareness
Inovor Technologies is developing a satellite to deliver space situational awareness services, enabling safer management of congested orbital environments and supporting future commercial operations.

Closed-loop, Highly Selective Metal Recovery for Li-ion Battery Recycling
Iondrive Technologies is scaling an environmentally friendly recycling process that recovers more than 95% of metals from spent lithium-ion batteries, validating products with international customers.

Commercialising Biodegradable TGA Registered Surgical Masks
Joey Australia Enterprise is advancing production of biodegradable surgical masks that meet regulatory standards, supporting Australian-made capability and commercial scale-up.

Benchtop Manufacturing Ramp Up
Kandui Technologies is scaling manufacturing of a crystalline silica-free benchtop material made from waste products, providing a safer alternative to engineered stone and supporting local jobs.

AI-enabled Fabric Sensors for Personalised Pressure Injury Prevention
Lenexa Medical is commercialising an AI-enabled fabric-based monitoring system that tracks patient pressure risks in hospitals and aged care, supporting earlier interventions and improved health outcomes.

High-bandwidth, Software-defined Test and Measurement Instrumentation
Liquid Instruments is commercialising the next generation of its Moku:RF device, integrating advanced signal processing hardware to support high-end aerospace, quantum and semiconductor applications with Australian pilot manufacturing.

Sovereign Capacity in High Tolerance Lithium Foil for Next-gen Batteries
Li-S Energy is scaling manufacturing of high-tolerance lithium foil needed for advanced batteries, reducing reliance on imported materials and improving domestic supply chain security.

Preventing Macular Blindness with Real-world Large-scale Data Analytics
Macuject is expanding its analytics platform to help ophthalmologists better treat age-related macular degeneration through large-scale clinical insights and improved treatment pathways.

Ambulance Head CT for Point-of-care Rapid Stroke Diagnosis
Micro-X is commercialising a compact head CT scanner using carbon nanotube X-ray technology for integration into ambulances, enabling faster stroke detection and improved emergency outcomes globally.

Commercialisation of Li-ion Locomotive Starter/Service Batteries
MLB Industrial is scaling production of lithium-ion batteries for starting and powering control systems in freight and passenger locomotives, supporting fleet upgrades and rail decarbonisation.

Nbryo’s Embryo Transfer Device: Beef & Dairy Productivity and Emissions Reductions
Nbryo is developing a scalable embryo transfer device to improve breeding efficiency in beef and dairy herds, conducting field trials to support commercial rollout in Australia and worldwide.

In-house Manufacturing and Local Assembly for Smart Parking Solutions
Parking Spotz is establishing Australian manufacturing for its robotic SmartBollard parking system, improving scalability, workflow efficiency and quality control while expanding robotics capability in Australia.

Popit HDPE Milk Bottle Recycling Pilot
Popit Recycling is commercialising a compact and cost-effective recycling machine that enables dairy processors to recycle HDPE milk bottles on-site, reducing manufacturing waste and emissions.

Manufacturing Affordable Methane-reducing Asparagopsis Seaweed Feed
Provectus Algae is constructing a large-scale Asparagopsis production facility to reduce livestock methane emissions, lowering production costs and supporting commercial adoption.

Cell-level Battery Control for E-mobility
Relectrify Holdings is commercialising its CellSwitch battery control technology to extend battery life, improve safety and enable longer-range electric vehicles without significant cost or mass increases.

Scale-up Manufacturing of JAZBI Bone Implant System
SDIP Innovations is commercialising a novel biomaterial implant platform designed to reduce recovery time and clinical complications, scaling manufacturing and advancing regulatory approvals.

Australian-made Ag Tech Scaled Up and Going Global
Seed Terminator is scaling international adoption of its crop-harvesting technology that destroys weed seeds with 99% effectiveness, improving yields and reducing reliance on chemical herbicides.

Manufacture of a Novel Genetic Testing Platform for Common Eye Diseases
Seonix is manufacturing and validating a genetic testing platform to identify disease risk for macular degeneration, myopia and keratoconus, supporting global commercial growth.

BIOINVISIBLE – an Infection-resistant Coating for Orthopaedic Implants
TekCyte is commercialising a novel coating that reduces micro-organism adhesion on implantable medical devices, helping prevent infection and reduce hospital stays, recovery complications and healthcare costs.

My DryEye – An Integrated Consumer Solution for Dry Eye Disease Management
Telemedc is developing an AI-enabled dry eye diagnostic and management system combining mobile imaging, algorithms and usability improvements to support better patient outcomes and home monitoring.

Synthetic Biopolymer Production Facility to Take Tetramatrix Global
Tetratherix is establishing Australia’s first advanced medical-grade polymer production capability, scaling from lab to commercial manufacturing while completing regulatory approvals and global market readiness.

Develop a Disruptive, Smart, Modular Industry 4.0 Compliant Conveyor System
Tetrisize Oceania will build and test a functional modular conveyor prototype with simplified local manufacturing and social enterprise employment pathways to support industrial automation adoption.

Project Archer – Commercialising Graphene Manufacturing
Turquoise Group is commercialising plasma torch methane pyrolysis technology to convert methane into high-value graphene and hydrogen with zero emissions, supporting future commercial-scale plant development.

Userdoc AI Knowledge Enablement
Userdoc is commercialising an AI-powered software requirements platform that improves documentation quality, reduces project risk and supports efficient delivery across global software development teams.

Powered E-Trailer Trials
Vibe Energy Motion is conducting large-scale trials of a powered e-trailer that integrates with modern trucks to deliver electrification without major infrastructure upgrades, helping reduce fuel costs and emissions.

PORA: Advanced 3D Passive Counter-drone Technology for Defence and Security
Visionary Machines is scaling its passive 3D drone detection system to protect defence and critical infrastructure assets by enabling undetectable, all-weather monitoring and tracking.

Export of Proprietary Protected Medical Device to US Military
Vitrafy Life Sciences is commercialising next-generation cryopreservation technology to support advanced cancer treatments, including scaling manufacturing and securing regulatory approvals for US deployment.

Scaling Operator XR
xReality Group is enhancing its portable VR training platform for military and law enforcement, expanding manufacturing capacity and introducing AI-driven real-time scenario training to accelerate global adoption.

Zetifi Smart Antenna Platform
Zetifi will develop and launch smart antenna systems for vehicles and machinery that extend mobile and satellite connectivity, scaling Australian-based manufacturing with automation and robotics to support full-scale production.

Scroll to Top